查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1479955

眼壓計市場 - 2024 年至 2029 年預測

Tonometer Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

眼壓計市場預計將從2022年的312,281,000美元成長到2029年的410,489,000美元，複合年成長率為3.98%。

使用眼壓計（一種攜帶式醫療設備）測量眼球內的眼壓和眼內液壓力。眼壓計由一個平頭探頭和一個金屬柱塞組成，可以輕輕地刷過眼表。

在嚴重的情況下，青光眼會損害視神經並導致失明。眼壓計不需要使用螢光素或局部麻醉劑，減少了感染疾病和角膜擦傷的風險。因此，它經常在醫院、眼科診所和眼科中心使用。

市場促進因素：

  • 眼壓計市場的預期擴張

青光眼在一般人群中盛行率的增加是眼壓計市場擴大的主要因素之一。老年人和糖尿病患者數量的增加加劇了眼壓計需求的快速成長。

醫療機構擴大使用阿普拉納西翁眼壓計也推動了眼壓計市場的成長。此測試通常用於測量眼內壓 (IOP)，以確定暫時壓平部分角膜所需的功率。此外，回彈眼壓計的進步正在推動眼壓計市場的成長。

  • 老年人和糖尿病患者的生長

近年來，人均壽命延長，老年人口數量不斷增加。從急性疾病轉變為慢性疾病的轉變，包括糖尿病、關節炎、高膽固醇和高血壓，是導致人類壽命下降的原因。

根據2019年聯合國全球老化調查，到2050年，全球將有15億人年齡在65歲或以上。老年病和其他慢性病的盛行率預計將隨著人口的成長而上升，從而推動全球眼壓計市場的擴張。

  • 增加眼科檢查營

及早發現和識別眼部疾病，包括青光眼和其他導致眼睛損傷的慢性疾病，可以預防視力喪失和失明。這種疾病的徵兆可以在定期眼科檢查中發現。

青光眼在早期階段不會表現出任何特殊症狀或警訊。因此，為了預防青光眼，提高大眾對青光眼的認知非常重要。定期眼科檢查和避免視力喪失的措施將進一步推動全球眼壓計市場。

  • 擴大脈動眼壓測試的使用

眼內壓測試測量眼球內的眼內液壓力。此測試測量暫時壓平角膜的一部分所需的壓力大小。它用於診斷青光眼，並刺激了眼壓計市場。

壓平眼壓計，例如卡爾蔡司製造的壓平眼壓計，是眼壓計的黃金標準，基於 Goldman 教授提出的想法精確測量眼內壓。眼壓測量對於許多眼科疾病尤其是青光眼的診斷和治療至關重要。

此外，與其他眼壓計設備的比較研究強調了其在診斷青光眼方面的有效性，並且預計對 Aplanacion 眼壓計的需求將會增加。例如，2022 年 8 月發表在《加拿大眼科雜誌》上的一項研究發現，與壓平眼壓測量設備相比，手持式眼壓測量設備經常低估眼壓 (IOP)。

手持式眼壓計低估眼壓可能導致青光眼診斷不足和治療不足，從而導致不可逆轉的視力喪失。因此，由於阿普拉納西翁眼壓計市場預計將顯著成長，與手持式眼壓計相比，阿普拉納西翁眼壓計往往會高估眼內壓。

  • 增加青光眼篩檢項目

商業、半私營和公共醫療保健部門計劃增加的青光眼篩檢計劃預計將在預測期內推動眼壓計行業的發展。對眼壓計的需求是由於人們對青光眼及其對視力的影響的了解不斷增加而引起的，而眼科篩檢營的數量不斷增加。

眼科檢查項目的增加預計也將推動眼壓計市場的成長。例如，「願景2020：視力權-印度」組織了全國社區眼科會議，並組織了免費眼科檢查診所，為眼科實踐及其成功提供平台。

  • 桌上型眼壓計預計將成長

動態輪廓眼壓計 (DCT) 和眼反應分析儀 (ORA) 等桌面眼壓計不依賴角膜的生化特性，用於測量眼壓。隨著越來越多的眼科手術（例如角膜移植、青光眼、白內障和其他屈光矯正手術）的進行，眼壓計市場預計將會發展。

為了有效治療這些疾病並節省未來的醫療費用，眼壓測量伴隨著對角膜動態特性的徹底分析。市售可攜式眼壓計包括回彈眼壓計、Perkins 眼壓計和張力筆。在預測期內，攜帶式眼壓計的便攜性、易用性和患者舒適度等因素預計將推動眼壓計市場的成長。

  • 擴大患者對早期診斷的了解

眼壓計市場預計將受到患者對早期診斷和定期眼壓（IOP）監測以防止不必要的視力喪失的認知的推動。一旦推出優惠的支付規則，醫院和診所眼壓計的使用預計將會增加。

例如，簡單且複雜的眼壓計（例如帕斯卡動態輪廓眼壓計）在美國屬於 III 類 CPT 0198T，並由保險公司 United Healthcare 承保。

  • 北美眼壓計市場預計將擴大。

預計在預測期內，北美將主導眼壓計市場。由於大公司的存在、青光眼的高盛行率以及完善的醫療保健系統，該地區的眼壓計市場正在擴大。

例如，根據墨西哥衛生署2022年11月發布的報告，同年墨西哥青光眼患者人數估計為150萬人。這種疾病在60歲以上的人中最常見。此外，據報導，墨西哥最常見的青光眼類型是原發性開角型青光眼。因此，該國青光眼的嚴重流行導致對眼壓計的需求增加，預計市場在預測期內將大幅成長。

增加研究合作和政府支持措施也是預計推動眼壓計產業擴張的其他因素。由於有利的醫療保健法律、龐大的患者基礎和成熟的醫療保健行業，預計美國將佔據眼壓計市場的最高佔有率。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章眼壓計市場：依技術分類

  • 介紹
  • 壓平眼壓測定
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 壓痕眼壓計
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 回彈眼壓測量
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 其他技術
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第6章眼壓計市場：依攜帶式類型

  • 介紹
  • 桌面
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 手持式
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第7章眼壓計市場：依最終用戶分類

  • 介紹
  • 醫院
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 眼科中心
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第8章眼壓計市場：按地區

  • 介紹
  • 北美洲
    • 依技術
    • 按便攜類型
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 依技術
    • 按便攜類型
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 依技術
    • 按便攜類型
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 依技術
    • 按便攜類型
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 依技術
    • 按便攜類型
    • 按最終用戶
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Haag-Streit
  • HEMC Medical
  • Reichert Technologies
  • Diaton
  • Jaggi Brothers
  • Advin Healthcare
  • Keeler
  • Takagi Japan
  • Inami
  • Nidek-Intl
簡介目錄
Product Code: KSI061613608

The Tonometer market is projected to witness a compound annual growth rate of 3.98% to grow to US$410.489 million by 2029, from US$312.281 million in 2022.

The intraocular and fluid pressure inside the eye is measured using a tonometer, a portable medical device. It consists of metal plunger-equipped flat-tipped probes that are gently brushed on the eye's surface.

It is used to identify and evaluate those at risk of glaucoma, which, in severe cases, can harm the optic nerve and result in blindness. Tonometers don't need fluorescein or topical anesthetic to use, and they lessen the risk of getting infections and corneal abrasions. As a result, hospitals, eye clinics, and ophthalmic centers frequently employ them.

MARKET DRIVERS:

  • Prospects for the tonometer market to expand

The increased prevalence of glaucoma among the general population is one of the primary drivers of the tonometer market rise. Further fueling the surge in tonometer demand is the growing elderly and diabetic populations, who are more vulnerable to eye-related conditions.

The increased use of applanation tonometry in healthcare facilities is also fueling tonometer market growth. The test is frequently used to determine intraocular pressure (IOP) since it determines how much power is required to temporarily flatten a section of the cornea. Additionally, rebound tonometry's advancement is promoting tonometer market growth.

  • Growth in geriatric and diabetic patients

Since the population's life expectancy has grown over the past several years, there are more elderly people in society. A change from acute to chronic disorders including diabetes, arthritis, high cholesterol, and hypertension, is the reason for the decrease in life expectancy of humans.

According to a 2019 United Nations World Ageing study, there will be 1.5 billion people who are 65 years of age or older worldwide by the year 2050. The prevalence of geriatric and other chronic illnesses would rise along with the population, which will propel the expansion of the worldwide tonometer market.

  • Increased number of eye check-up camps

Vision loss and blindness might be avoided via early identification of and detection of ophthalmic disorders including glaucoma and other chronic diseases causing eye difficulties. The signs of the disorders might be identified with routine eye exams.

Glaucoma does not initially exhibit any particular symptoms or warning signals. Therefore, raising public knowledge of the condition may be crucial in preventing it; regular eye exams and measures to avoid vision loss further boost the worldwide tonometer market.

  • The growing use of applanation tonometry

The applanation tonometry test determines the eye's intraocular fluid pressure. The test measures the pressure needed to temporarily flatten a section of the cornea. It is employed in glaucoma diagnosis and is fueling the tonometer market.

The gold standard in tonometry, applanation tonometers from firms like Carl Zeiss give accurate measures of intraocular pressure (IOP) based on the idea presented by Professor Goldmann. IOP measurement is an essential part of the diagnosis and treatment of many eye diseases, particularly glaucoma.

Additionally, the demand for applanation tonometry is anticipated to rise due to comparative studies with other tonometry devices, highlighting its effectiveness in diagnosing glaucoma. For example, research published in the Canadian Journal of Ophthalmology in August 2022 revealed that handheld rebound tonometry devices often underestimate intraocular pressure (IOP) when compared to applanation tonometry.

This underestimation of IOP with handheld rebound tonometry may result in the underdiagnosis and undertreatment of glaucoma, leading to irreversible vision loss. Consequently, the market is expected to experience significant growth as a result of applanation tonometry's tendency to overestimate IOP compared to handheld rebound tonometry.

  • The rising number of glaucoma screening programs

A rise in glaucoma screening programs planned by the commercial, semi-public, and public healthcare sectors is anticipated to promote tonometer industry development throughout the projected period. The need for tonometers is driven by the growth in knowledge of glaucoma and its effects on vision brought on by the growing number of eye checkup camps.

Increased eye screening programs are also anticipated to promote tonometer market growth. For instance, Vision 2020: The Right to Sight - India conducted a national conference on community ophthalmology and held free eye screening clinics to provide a platform for eye care practices and their successful administration.

  • Desktop tonometers are expected to grow

IOP is measured using desktop tonometers like the Dynamic Contour Tonometer (DCT) and Ocular Response Analyzer (ORA), which are not reliant on the biochemical characteristics of the cornea. The tonometer market is anticipated to develop as more eye procedures including keratoplasty, glaucoma, cataract, and other refractive operations are performed.

To effectively treat these diseases and save on future medical expenses, IOP measurements are being accompanied by a thorough analysis of the cornea's biomechanical features. Commercially available portable tonometers include rebound tonometers, Perkins tonometers, and tono-pens. Throughout the forecast period, factors such as the portable tonometer's portability, ease of use, and improved patient comfort are anticipated to propel the tonometer market growth.

  • Greater patient understanding of the early diagnosis

The tonometer market is expected to be driven by increased patient awareness of early diagnosis and routine intraocular pressure (IOP) monitoring to prevent unnecessary vision loss. If beneficial payment rules are put in place, tonometer use in hospitals and clinics is anticipated to increase.

For instance, the cost of both simple and complex tonometers, such as the Pascal dynamic contour tonometer, is covered by insurance carrier United Healthcare in the United States under Category III CPT 0198T.

  • It is projected that the North American tonometer market will expand.

North America is predicted to dominate the tonometer market during the forecast period. The tonometer market is expanding as a result of the existence of large businesses, the high rate of glaucoma in the region, and the established healthcare system.

For example, according to a report released by the Ministry of Health in Mexico in November 2022, it is estimated that there are 1.5 million individuals living with glaucoma in Mexico in the same year. This condition is predominantly observed in individuals aged 60 and above. Furthermore, the most prevalent form of glaucoma in Mexico is reported to be open-angle primary glaucoma. Consequently, the substantial prevalence of glaucoma cases in the country leads to an increased demand for tonometers, which is expected to drive significant market growth throughout the projected period.

Growth in the number of research collaborations as well as supportive government initiatives are some other factors projected to fuel the tonometer industry expansion. The United States is anticipated to hold the highest share in this tonometer market as a result of beneficial healthcare laws, a sizable patient base, and an established healthcare industry.

Market Key Developments

  • In May 2023, The Tono-Vera(R) Tonometer with ActiViewTM Positioning System was launched by Reichert Technologies, a division of AMETEK, Inc., a pioneer in the field of eye care diagnostic equipment.
  • In April 2023, NIDEK responded to the market's growing demand for tonometer and ensured NIDEK's dependability by introducing the NT-1/1e Non-Contact Tonometer without a pachymetry feature.
  • In March 2022, iCare Home2, the Self-tonometer was approved by FDA. IOP readings are being collected with the iCare Home2 even while a patient is lying down.

Segmentation:

By Technology

  • Applanation Tonometry
  • Indentation Tonometry
  • Rebound Tonometry
  • Other Technologies

By Portability Type

  • Desktop
  • Handheld

By End-User

  • Hospitals
  • Ophthalmic Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. TONOMETER MARKET, BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Applanation Tonometry
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Indentation Tonometry
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Rebound Tonometry
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Other Technologies
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. TONOMETER MARKET, BY PORTABILITY TYPE

  • 6.1. Introduction
  • 6.2. Desktop
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Handheld
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. TONOMETER MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Ophthalmic Centers
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. TONOMETER MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technology
    • 8.2.2. By Portability Type
    • 8.2.3. By End Users
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Technology
    • 8.3.2. By Portability Type
    • 8.3.3. By End Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Technology
    • 8.4.2. By Portability Type
    • 8.4.3. By End Users
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Technology
    • 8.5.2. By Portability Type
    • 8.5.3. By End Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Technology
    • 8.6.2. By Portability Type
    • 8.6.3. By End Users
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Haag-Streit
  • 10.2. HEMC Medical
  • 10.3. Reichert Technologies
  • 10.4. Diaton
  • 10.5. Jaggi Brothers
  • 10.6. Advin Healthcare
  • 10.7. Keeler
  • 10.8. Takagi Japan
  • 10.9. Inami
  • 10.10. Nidek-Intl